Novo Nordisk A/S (NVO)
US$ 64.85-4%
Price Chart
Key Statistics
Market Cap
$ 306.3B
P/E Ratio
20.18
Revenue (TTM)
$ 290.4B
Volume
11.58M
52W High
$ 145.26
52W Low
$ 57.00
Dividend Yield
2.33%
Beta
0.21
Technicals
50-Day MA
73.1844
200-Day MA
101.5936
52 Week High
145.2569
52 Week Low
57
About NVO
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, .
Employees
76302
Headquarters
Bagsvaerd, Denmark
CEO
Mr. Lars Fruergaard Jorgensen
Latest News
Novo Nordisk shares pop as drugmaker sees copycat Wegovy sales easing in 2025 - CNBC
2 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg